FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
What Are the MDMA Risks of Therapy for PTSD?news2024-06-04T22:12:47+00:00June 4th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
Drugs, Sacraments or Medicine? Psychedelic Churches Blur the Line.news2024-05-12T09:01:41+00:00May 12th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
More Young People Are on Multiple Psychiatric Drugs, Study Findsnews2024-02-16T17:25:11+00:00February 16th, 2024|The New York Times|
Use of ADHD Drugs Surged During Pandemic, Study Findsnews2024-01-10T17:25:09+00:00January 10th, 2024|The New York Times|
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billionnews2023-12-22T17:55:31+00:00December 22nd, 2023|The New York Times|
What to Know About the Effects of Ketaminenews2023-12-16T16:55:07+00:00December 16th, 2023|The New York Times|